The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation

FASEB Journal

Volumn 22, Issue 2, 2008, Pages 418-427

  Collet, C ^a   Schiltz, C ^a   Geoffroy, V ^a   Maroteaux, L ^b   Launay, J M ^a   De Vernejoul, M C ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b INSTITUT DU FER À MOULIN   (France)

Author keywords

Aging; Neurotransmitter; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; SEROTONIN RECEPTOR; SEROTONIN 5 RECEPTOR;

AGING; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE MASS; CELL DIFFERENTIATION; CELL PROLIFERATION; COLONY FORMING UNIT; FEMALE; IN VIVO STUDY; MALE; MOUSE; NEUROTRANSMISSION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CULTURE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLIC BONE DISEASE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

MUS;

AGING; ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION REGULATION; MICE; MICE, KNOCKOUT; OSTEOBLASTS; RECEPTORS, SEROTONIN;

EID: 38949152272     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-9209com     Document Type: Article

References (46)

1. Raisz, L. G. (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J. Clin. Invest. 115, 3318-3325
2. Lundberg, P., Lundgren, I., Mukohyama, H., Lehenkari, P. P., Horton, M. A., and Lerner, U. H. (2001) Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors. Endocrinology 142, 339-347
3. Lerner, U. H. (2006) Deletions of genes encoding calcitonin/ α-CGRP, amylin and calcitonin receptor have given new and unexpected insights into the function of calcitonin receptors and calcitonin receptor-like receptors in bone. J. Musculoskelet. Neuronal Interact. 6, 87-95
4. Suzuki, A., Palmer, G., Bonjour, J. P., and Caverzasio, J. (1998) Catecholamines stimulate the proliferation and alkaline phosphatase activity of MC3T3-E1 osteoblast-like cells. Bone 23, 197-203
5. Taylor, A. F. (2002) Osteoblastic glutamate receptor function regulates bone formation and resorption. J. Musculoskelet. Neuronal Interact. 2, 285-290
6. Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M., and Karsenty, G. (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207
7. Elefteriou, F., Ahn, J. D., Takeda, S., Starbuck, M., Yang, X., Liu, X., Kondo, H., Richards, W. G., Bannon, T. W., Noda, M., Clement, K., Vaisse, C., and Karsenty, G. (2005) Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434, 514-520
8. Sanders-Bush, E., and Mayer, S.E. (2005) 5-Hydroxytryptamine (serotonin): receptor agonists and antagonists. In Goodman and Gilman's the Pharmacological Basis of Therapeutics, 11th ed (Brunton, L. L., Lazo, J. S., and Keith, L. P., eds) pp. 297-316, McGraw-Hill, Columbus, OH
9. Hoyer, D., Hannon, J. P., and Martin, G. R. (2002) Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol. Biochem. Behav. 71, 533-554
10. Warden, S. J., Bliziotes, M. M., Wiren, K. M., Eshleman, A. J., and Turner, C. H. (2005) Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine). Mol. Cell. Endocrinol. 242, 1-9
11. Bliziotes, M. M., Eshleman, A. J., Zhang, X. W., and Wiren, K. M. (2001) Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake. Bone 29, 477-486
12. Warden, S. J., Robling, A. G., Sanders, M. S., Bliziotes, M. M., and Turner, C. H. (2005) Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 146, 685-693
13. Westbroek, I., van der Plas, A., de Rooij, K. E., Klein-Nulend, J., and Nijweide, P. J. (2001) Expression of serotonin receptors in bone. J. Biol. Chem. 276, 28961-28968
14. Bliziotes, M., Eshleman, A., Burt-Pichat, B., Zhang, X. W., Hashimoto, J., Wiren, K., and Chenu, C. (2006) Serotonin transporter and receptor expression in osteocytic MLO-Y4 cells. Bone 39, 1313-1321
15. Gustafsson, B. I., Thommesen, L., Stunes, A. K., Tommeras, K., Westbroek, I., Waldum, H. L., Slordahl, K., Tamburstuen, M. V., Reseland, J. E., and Syversen, U. (2006) Serotonin and fluoxetine modulate bone cell function in vitro. J. Cell Biochem. 98, 139-151
16. Shuey, D. L., Sadler, T. W., and Lauder, J. M. (1992) Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors. Teratology 46, 367-378
17. Moiseiwitsch, J. R. (2000) The role of serotonin and neurotransmitters during craniofacial development. Crit. Rev. Oral. Biol. Med. 11, 230-239
18. Choi, D. S., Ward, S. J., Messaddeq, N., Launay, J. M., and Maroteaux, L. (1997) 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells. Development 124, 1745-1755
19. 2B receptor signaling: nitric oxide production and phospholipase A2 activation. Cell Signal. 18, 628-639
20. 2B receptor. J. Biol. Chem. 271, 3141-3147
21. Nebigil, C. G., Choi, D. S., Dierich, A., Hickel, P., Le Meur, M., Messaddeq, N., Launay, J. M., and Maroteaux, L. (2000) Serotonin 2B receptor is required for heart development. Proc. Natl. Acad. Sci. U. S. A. 97, 9508-9513
22. Merciris, D., Marty, C., Collet, C., de Vernejoul, M. C., and Geoffroy, V. (2007) Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo. Am. J. Pathol. 170, 1676-1685
23. Parfitt, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M., and Recker, R. R. (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units: report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610
24. Geoffroy, V., Marty-Morieux, C., Le Goupil, N., Clement-Lacroix, P., Terraz, C., Frain, M., Roux, S., Rossert, J., and de Vernejoul, M. C. (2004) In vivo inhibition of osteoblastic metalloproteinases leads to increased trabecular bone mass. J. Bone Miner. Res. 19, 811-822
25. Kellermann, O., Loric, S., Maroteaux, L., and Launay, J. M. (1996) Sequential onset of three 5-HT receptors during the 5-hydroxytryptaminergic differentiation of the murine 1C11 cell line. Br. J. Pharmacol. 118, 1161-1170
26. Chen, T. L. (2004) Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone 35, 83-95
27. Battaglino, R., Fu, J., Spate, U., Ersoy, U., Joe, M., Sedaghat, L., and Stashenko, P. (2004) Serotonin regulates osteoclast differentiation through its transporter. J. Bone Miner. Res. 19, 1420-1431
28. Parfitt, A. M., Villanueva, A. R., Foldes, J., and Rao, D. S. (1995) Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J. Bone Miner. Res. 10, 466-473
29. Jilka, R. L., Weinstein, R. S., Takahashi, K., Parfitt, A. M., and Manolagas, S. C. (1996) Linkage of decreased bone mass with impaired osteoblastogenesis in a murine model of accelerated senescence. J. Clin. Invest. 97, 1732-1740
30. 2B receptor and retinoic acid in the embryonic mouse hindlimb. Dev. Dyn. 230, 201-209
31. 2B receptor in the mouse frontonasal mass. Anat. Embryol. (Berl.) 208, 135-143
32. Bonyadi, M., Waldman, S. D., Liu, D., Aubin, J. E., Grynpas, M. D., and Stanford, W. L. (2003) Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc. Natl. Acad. Sci. U. S. A. 100, 5840-5845
33. Stenderup, K., Justesen, J., Clausen, C., and Kassem, M. (2003) Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 33, 919-926
34. Meunier, P., Aaron, J., Edouard, C., and Vignon, G. (1971) Osteoporosis and the replacement of cell populations of the marrow by adipose tissue: a quantitative study of 84 iliac bone biopsies. Clin. Orthop. Relat. Res. 80, 147-154
35. Kajkenova, O., Lecka-Czernik, B., Gubrij, I., Hauser, S. P., Takahashi, K., Parfitt, A. M., Jilka, R. L., Manolagas, S. C., and Lipschitz, D. A. (1997) Increased adipogenesis and myelopoiesis in the bone marrow of SAMP6, a murine model of defective osteoblastogenesis and low turnover osteopenia. J. Bone Miner. Res. 12, 1772-1779
36. Lesurtel, M., Graf, R., Aleil, B., Walther, D. J., Tian, Y., Jochum, W., Gachet, C., Bader, M., and Clavien, P. A. (2006) Platelet-derived serotonin mediates liver regeneration. Science 312, 104-107
37. Nebigil, C. G., Launay, J. M., Hickel, P., Tournois, C., and Maroteaux, L. (2000) 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc. Natl. Acad. Sci. U. S. A. 97, 2591-2596
38. Cheng, S. L., Shin, C. S., Towler, D. A., and Civitelli, R. (2000) A dominant negative cadherin inhibits osteoblast differentiation. J. Bone Miner. Res. 15, 2362-2370
39. Shin, C. S., Lecanda, F., Sheikh, S., Weitzmann, L., Cheng, S. L., and Civitelli, R. (2000) Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways. J. Cell Biochem. 78, 566-577
40. Kubera, M., Maes, M., Kenis, G., Kim, Y. K., and Lason, W. (2005) Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor α and interleukin-6. Psychiatry Res. 134, 251-258
41. 2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1β, and tumor necrosis factor-α cytokine production by ventricular fibroblasts. Circulation 110, 969-974
42. Franchimont, N., Wertz, S., and Malaise, M. (2005) Interleukin-6: an osteotropic factor influencing bone formation? Bone 37, 601-606
43. Ruddell, R. G., Oakley, F., Hussain, Z., Yeung, I., Bryan-Lluka, L. J., Ramm, G. A., and Mann, D. A. (2006) A role for serotonin (5-HT) in hepatic stellate cell function and liver fibrosis. Am. J. Pathol. 169, 861-876
44. Watts, S. W., and Thompson, J. M. (2004) Characterization of the contractile 5-hydroxytryptamine receptor in the renal artery of the normotensive rat. J. Pharmacol. Exp. Ther. 309, 165-172
45. 2B receptor signaling in serotonergic neuronal cells. FASEB J. 20, 1843-1854
46. 2B receptors in mice. J. Pharmacol. Exp. Ther. 317, 724-731